Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China flag China · Delayed Price · Currency is CNY
22.68
+0.36 (1.61%)
Apr 1, 2025, 2:45 PM CST

SHE:002262 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Jan '23 Jan '22 Dec '20 2019 - 2015
Operating Revenue
5,6384,9764,2553,9193,344
Upgrade
Other Revenue
59.6165.6343.4916.5316.99
Upgrade
Revenue
5,6985,0424,2993,9363,361
Upgrade
Revenue Growth (YoY)
13.01%17.29%9.22%17.09%-18.99%
Upgrade
Cost of Revenue
1,5461,4031,037932.68843.14
Upgrade
Gross Profit
4,1523,6383,2623,0032,518
Upgrade
Selling, General & Admin
2,2441,9441,8471,7431,443
Upgrade
Research & Development
595.65549.32454.25351.73245.86
Upgrade
Other Operating Expenses
65.6560.257.4654.0445.61
Upgrade
Operating Expenses
2,9392,5692,3602,1561,737
Upgrade
Operating Income
1,2131,070901.63847.28781.53
Upgrade
Interest Expense
-4.03-4.16-4.95-5.06-1.59
Upgrade
Interest & Investment Income
87.8274.8561.853.9248.32
Upgrade
Currency Exchange Gain (Loss)
0.170.410.91-1.14-0.38
Upgrade
Other Non Operating Income (Expenses)
-1.9-0.74-3.19-1.621.43
Upgrade
EBT Excluding Unusual Items
1,2951,140956.2893.38829.31
Upgrade
Impairment of Goodwill
-----0.82
Upgrade
Gain (Loss) on Sale of Assets
0.290.150.37-0.24-0.15
Upgrade
Asset Writedown
0.070.22-0.28-0.74-0.21
Upgrade
Other Unusual Items
0.9928.3233.6223.3822.35
Upgrade
Pretax Income
1,2971,169989.91915.78850.48
Upgrade
Income Tax Expense
155.9134.4109.82117.75123.37
Upgrade
Earnings From Continuing Operations
1,1411,034880.09798.02727.1
Upgrade
Minority Interest in Earnings
2.772.6720.62-0.241.72
Upgrade
Net Income
1,1441,037900.71797.78728.82
Upgrade
Net Income to Common
1,1441,037900.71797.78728.82
Upgrade
Net Income Growth
10.29%15.12%12.90%9.46%9.88%
Upgrade
Shares Outstanding (Basic)
1,0121,0071,0121,0101,012
Upgrade
Shares Outstanding (Diluted)
1,0121,0071,0121,0101,012
Upgrade
Shares Change (YoY)
0.53%-0.53%0.22%-0.24%0.72%
Upgrade
EPS (Basic)
1.131.030.890.790.72
Upgrade
EPS (Diluted)
1.131.030.890.790.72
Upgrade
EPS Growth
9.71%15.73%12.66%9.72%9.09%
Upgrade
Free Cash Flow
466.07634.31533.27495.01979.74
Upgrade
Free Cash Flow Per Share
0.460.630.530.490.97
Upgrade
Dividend Per Share
0.3600.3200.2000.2000.100
Upgrade
Dividend Growth
12.50%60.00%-100.00%-
Upgrade
Gross Margin
72.87%72.17%75.88%76.30%74.92%
Upgrade
Operating Margin
21.29%21.22%20.97%21.53%23.25%
Upgrade
Profit Margin
20.07%20.57%20.95%20.27%21.68%
Upgrade
Free Cash Flow Margin
8.18%12.58%12.41%12.58%29.15%
Upgrade
EBITDA
1,3641,2051,025959.57878.36
Upgrade
EBITDA Margin
23.95%23.90%23.84%24.38%26.13%
Upgrade
D&A For EBITDA
151.16135.14123.12112.2896.83
Upgrade
EBIT
1,2131,070901.63847.28781.53
Upgrade
EBIT Margin
21.29%21.22%20.97%21.53%23.25%
Upgrade
Effective Tax Rate
12.02%11.50%11.09%12.86%14.51%
Upgrade
Revenue as Reported
5,6985,0424,2993,9363,361
Upgrade
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.